Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 13/20 | 0.91 |
| ▸ | CA1 | P00915 | 13/20 | 0.91 |
| ▸ | CA9 | Q16790 | 13/20 | 0.91 |
| ▸ | CA2 | P00918 | 11/20 | 0.91 |
| ▸ | MGLL | Q99685 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | EHMT2 | Q96KQ7 | 2/20 | 0.50 |
| ▸ | EHMT1 | Q9H9B1 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2380360 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4389382 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4530702 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2378770 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2382500 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4513484 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL4398000 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL2475352 | 1.00 | CA12 (0.91) | CA12CA1CA9CA2MGLL | |
| SCHEMBL968412 | 0.98 | CA12 (0.87) | CA12CA1CA9CA2MGLL | |
| SCHEMBL7117660 | 0.98 | CA12 (0.87) | CA12CA1CA9CA2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0562172-B1 | Engine oil composition | IDEMITSU KOSAN CO (JP) | 1999-03-17 | — | — | EP | claimed |
| US-5458807-A | OF A BASE OIL, A BORON DERIVATIVE OF ALKENYLSUCCINIMIDE, AN ALKALINE EARTH METAL SALT OF SALICYLIC ACID AND MOLYBDENUM DITHIOPHOSPHATE OR MOLYBDENUM DITHIOCARBAMATE | IDEMITSU KOSAN CO., LTD. (JP) | 1995-10-17 | — | — | US | claimed |
| EP-0562172-A1 | Engine oil composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-29 | — | — | EP | claimed |
| US-12630779-B2 | Transmission lubricants containing molybdenum | AFTON CHEMICAL CORPORATION (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4709825-A1 | LOW DISPERSANT HIGH VI ENGINE OIL FOR IMPROVED FUEL ECONOMY | Chevron Oronite Company LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12552980-B2 | Oil soluble molybdenum complexes as high temperature fouling inhibitors | ECOLAB USA INC (US) | 2026-02-17 | — | — | US | disclosed |
| US-20260035634-A1 | LUBRICATING OIL COMPOSITION FOR CORROSION CONTROL | CHEVRON ORONITE CO (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4306624-B1 | TRANSMISSION LUBRICANTS CONTAINING MOLYBDENUM | AFTON CHEMICAL CORP (US) | 2025-09-17 | — | — | EP | disclosed |
| US-12391898-B2 | Friction modifier system | Chevron Japan Limited (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-4341365-B1 | LOW ASH LUBRICATING OIL COMPOSITION | CHEVRON JAPAN LTD (JP) | 2025-07-16 | — | — | EP | disclosed |
| EP-4565671-A1 | LUBRICATING OIL COMPOSITION FOR CORROSION CONTROL | Chevron Oronite Company LLC (US) | 2025-06-11 | — | — | EP | disclosed |
| EP-0633304-B1 | Urea grease composition | SHOWA SHELL SEKIYU (JP) | 1998-02-25 | — | — | EP | disclosed |
| US-5624889-A | OIL WITH THICKENERS SUCH AS CALCIUM PHOSPHATE AND TRIPHENYL PHOSPHOROTHIONATE | SHOWA SHELL SEKIYU K.K. (JP) | 1997-04-29 | — | — | US | disclosed |
| EP-0714975-A1 | Lubricating grease composition | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1996-06-05 | — | — | EP | disclosed |
| US-5458807-A | OF A BASE OIL, A BORON DERIVATIVE OF ALKENYLSUCCINIMIDE, AN ALKALINE EARTH METAL SALT OF SALICYLIC ACID AND MOLYBDENUM DITHIOPHOSPHATE OR MOLYBDENUM DITHIOCARBAMATE | IDEMITSU KOSAN CO., LTD. (JP) | 1995-10-17 | — | — | US | disclosed |
| US-5449471-A | For constant velocity universal joints, molybdenum dithiocarbamate compound, triphenyl phosphorothionate | SHOWA SHELL SEIKYU K.K. (JP) | 1995-09-12 | — | — | US | disclosed |
| US-5445749-A | Lubricating metal-ceramic interface with composition of carrier fluid and copper, cobalt, nickel, tungsten, titanium, manganese, molybdenum, iron, chromium, vanadium or rare earth thiocarbamate; improving wear performance | THE LUBRIZOL CORPORATION (US) | 1995-08-29 | — | — | US | disclosed |
| EP-0633304-A1 | Urea grease composition | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1995-01-11 | — | — | EP | disclosed |
| EP-0562172-A1 | Engine oil composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-09-29 | — | — | EP | disclosed |
| US-4609480-A | MIXTURE OF OIL ADDITIVES | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1986-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035634-A1 | LUBRICATING OIL COMPOSITION FOR CORROSION CONTROL | NFKBIA, IKBKB, TH | CA12 3853/4885CA1 2524/4885CA9 2827/4885 |
| US-12630779-B2 | Transmission lubricants containing molybdenum | ZKSCAN2, ZFR, SLC39A11 | CA12 1373/4885CA1 496/4885CA9 2734/4885 |
| US-12552980-B2 | Oil soluble molybdenum complexes as high temperature fouling inhibitors | DSG1, SLC40A1, SLC9A5 | CA12 2954/4885CA1 1846/4885CA9 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.